ABSTRACr Twenty patients with carcinoma of the lung and a brain metastasis have undergone combined lung and brain surgery, which was synchronous in five. There were no operative deaths. Survival from the first surgical intervention was less than one year (3-10 months) in four patients (20%), one to two years in four (20%) and more than two years (26-66 months) in five patients (25%). Seven patients (35%) are alive and well after an average period of three years and three months (15-66 months). Actuarial survival at five years is 33.6%. All patients had severe neurological symptoms and 18 (90%) had a complete remission. Our experience and data reported in the literature point to the effectiveness of combined lung and brain surgery in prolonging symptom free survival in patients with lung cancer and solitary brain metastasis.
The survival of patients with lung cancer and brain metastasis is rather poor' 2 and seems not to be influenced by chemotherapy or radiotherapy, even from the point of view of the quality of life.3 The increasing evidence of encouraging results in published reports, and the possibility of a more accurate selection of patients with solitary brain metastasis by means of computed tomography, led us to consider combined surgical resection for lung cancer with brain metastasis. This paper reports our seven year experience of 20 patients with special reference to length of survival and management of the neurological symptoms. Our results (no operative mortality and a 60% survival rate one year after the second surgical intervention) provide further support for the use of this procedure as a means of prolonging the patient' s life and relieving many of the distressing and disabling symptoms. Our series, as well as others reported, shows that resection of the brain metastasis is the most effective way of obtaining prolonged remission of the neurological symptoms. Radiotherapy to the brain after resection of the brain metastasis is reported to have a beneficial effect in prolonging the symptom free period.' 2 The better results in our series (even without irradiation of the brain) than in those previously published may be attributed to a better selection of patients for combined surgery. The use of computed tomography helps to identify patients who really have only a single intracranial metastasis and the radionuclide investigations help to exclude distant metastases at other sites.
